8.9
Immunologisches Gedächtnis und weitere Aspekte von CRISPR
Das CRISPR-Cas-System dient als bakterieller Abwehrmechanismus gegen eindringendes genetisches Material wie Viren und Plasmide. Diese Funktion bildet…
Das CRISPR-Cas-System schützt die Bakterien vor fremden genetischen Elementen.
In Laboren wird das System mit Cas-9 programmiert, um Gene in Pflanzen, Tieren und Menschen zu bearbeiten.
Cas9, eine Endonuklease aus Streptococcus pyogenes, wird mit einer synthetischen Leit-RNA - sgRNA - in die Zellen abgegeben.
Die sgRNA leitet Cas9 zur Protospacer-Sequenz des benachbarten Motivs, wodurch es die DNA an der Zielstelle binden und schneiden kann.
Für die Geninsertion spaltet Cas9, gesteuert von einer sgRNA, die Stelle, was eine homologe Rekombination zum Einfügen des neuen Gens ermöglicht.
Für die Gendeletion weisen zwei sgRNAs Cas9 an, beide Enden der Zielregion zu durchtrennen.
Das Gen wird herausgeschnitten und das Reparatursystem verbindet die abgeschnittenen Enden.
CRISPR-Cas9 wurde entwickelt, um HIV zu inaktivieren, indem seine DNA aus infizierten Zellen herausgeschnitten wird. Technisch hergestellte Systeme wie Csy4 zielen auf freie HIV-RNA ab, obwohl diese Methoden noch experimentell sind.
CRISPR-Cas9 zielt nicht nur auf einen einzelnen Locus ab, sondern kann auch mehrere Gene gleichzeitig bearbeiten, z. B. mehrere retrovirale Kopien entfernen.
View the full transcript and gain access to JoVE Core videos
Q1: How does Cas9 identify and cut DNA at the target site?
Cas9, an endonuclease from Streptococcus pyogenes, uses a synthetic guide RNA (sgRNA) to locate specific DNA sequences. The sgRNA directs Cas9 to the Protospacer Adjacent Motif (PAM) sequence, typically 5'-NGG-3', allowing Cas9 to bind and introduce a double-stranded break at the precise target location.
Q2: What is the difference between gene insertion and gene deletion using CRISPR-Cas9?
Gene insertion uses one sgRNA to guide Cas9 to cleave a site, then homologous recombination inserts new genetic material. Gene deletion employs two sgRNAs directing Cas9 to cut both ends of a target region, excising the DNA fragment, which the cell's repair system then rejoins through non-homologous end joining.
Q3: How can CRISPR-Cas9 be used to treat HIV infections?
CRISPR-Cas9 has been designed to inactivate HIV by excising integrated viral DNA from infected cells. Additionally, engineered systems like Csy4 target free HIV RNA to degrade it, though these antiviral strategies remain experimental and represent emerging therapeutic approaches for combating viral infections.
Q4: What is the original function of the CRISPR-Cas system in bacteria?
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids. Originally discovered in prokaryotes, the antiviral system of bacteria and archaea has been repurposed as a powerful genome-editing tool for laboratory applications across diverse organisms.
Q5: Can CRISPR-Cas9 edit multiple genes simultaneously?
Yes, CRISPR-Cas9 enables multiplexed genome editing, allowing simultaneous modification of multiple genes in a single organism. This capability is particularly advantageous in complex genetic studies and therapeutic applications, such as removing multiple retroviral copies from infected cells in one editing event.
Q6: What organisms can be edited using CRISPR-Cas9 technology?
CRISPR-Cas9 has been reprogrammed to modify the genomes of diverse organisms, including plants, animals, and humans. This versatility makes it a revolutionary tool for genetic engineering across a wide range of biological systems and research applications in both basic and applied science.
Q7: How does the synthetic guide RNA direct Cas9 to the correct DNA location?
The synthetic single guide RNA (sgRNA) contains a complementary sequence that guides Cas9 to a specific genomic locus adjacent to the Protospacer Adjacent Motif (PAM). This precise targeting ensures Cas9 binds and cuts only at the intended DNA location, enabling accurate and efficient genome editing with minimal off-target effects.